BridgeBio Pharma, Inc. (BBIO) earnings: date, estimates, results and stock reactions
Over the last 12 reports the stock moved 3.0% on average (either way), rising 5 times and falling 7. EPS beat estimates 5 of 12 times; revenue 8 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-29 | -0.42 | -0.54 | +22.5% | 353.2M | 293.5M | +5.8% |
| Q2 FY2026 | 2026-08-10 | -0.78 | -0.58 | -35.5% | 243.7M | 220.9M | -0.9% |
| Q1 FY2026 | 2026-05-07 | -0.84 | -0.68 | -23.8% | 194.5M | 178.1M | -1.0% |
| Q4 FY2025 | 2026-02-24 | -1.00 | -0.71 | -40.2% | 154.2M | 146.8M | -2.0% |
| Q3 FY2025 | 2025-10-29 | -0.95 | -0.88 | -8.0% | 120.7M | 148.2M | -1.8% |
| Q2 FY2025 | 2025-08-05 | -0.95 | -0.83 | -14.5% | 110.6M | 108.1M | -6.2% |
| Q1 FY2025 | 2025-04-29 | -0.88 | -1.00 | +12.0% | 116.6M | 68.4M | +6.9% |
| Q4 FY2024 | 2025-02-20 | -1.31 | -1.09 | -20.2% | 5.9M | 4.0M | +1.5% |